Obstet Gynecol. 2015 Nov;126(5):e100-7. doi: 10.1097/AOG.0000000000001150.
Inclusion of women in research studies is necessary for valid inferences about health and disease in women. The generalization of results from trials conducted in men may yield erroneous conclusions that fail to account for the biologic differences between men and women. Although significant changes in research design and practice have led to an increase in the proportion of women included in research trials, knowledge gaps remain because of a continued lack of inclusion of women, especially those who are pregnant, in premarketing research trials. This document provides a historical overview of issues surrounding women as participants in research trials, followed by an ethical framework and discussion of the issues of informed consent, contraception requirements, intimate partner consent, and the appropriate inclusion of pregnant women in research studies.
将女性纳入研究对于得出有关女性健康与疾病的有效推断是必要的。从针对男性进行的试验中得出的结果进行推广,可能会产生错误结论,而这些结论未能考虑到男性和女性之间的生物学差异。尽管研究设计和实践方面的重大变化已导致纳入研究试验的女性比例有所增加,但由于在上市前研究试验中持续缺乏对女性(尤其是孕妇)的纳入,知识差距仍然存在。本文档提供了围绕女性作为研究试验参与者的问题的历史概述,随后是一个伦理框架,并讨论了知情同意、避孕要求、亲密伴侣同意以及孕妇在研究中的适当纳入等问题。